Health Care Law News and Insights

On Jan. 15, 2025, the U.S. Food and Drug Administration revoked its authorization for the use of Red Dye No. 3 in food and ingested medications. Red Dye No. 3, chemically known as erythrosine, is a synthetic color additive made from petroleum that is used to give foods and beverages a bright...

Read More

McKinsey & Company, Inc., has entered into a deferred prosecution agreement (DPA) to resolve a federal criminal investigation into its advice to Purdue Pharma L.P. (Purdue) on how to increase sales of OxyContin, and a civil settlement to resolve allegations that it provided advice that resulted in the submission of...

Read More

Of the one million people in the U.S. living with Parkinson's disease (PD), more than 300,000 are hospitalized each year. While hospitalized, a person with PD faces significant risk of preventable harm as a result of care complications, including deterioration of motor symptoms (28% of patients), increased likelihood of readmission...

Read More